Photocure ASA: Results for the second quarter of 2021
Oslo, Norway, 11 August 2021: Photocure ASA (OSE:PHO) today reported Hexvix[®]/Cysview[®] revenues of NOK 88.9 million in the second quarter of 2021 (Q2 2020: NOK 53.5), and EBITDA of NOK 5.8 million (NOK -8.9 million), driven by growth in the U.S. segment and the continued successful launch in European markets reacquired in 2020. Despite business challenges due to ongoing surges of Covid-19 and its variants in certain territories, Photocure plans to increase investment in commercial activities in the second half of 2021 to capitalize on improving access to care and to further penetrate the